Use of vasopressin in a canine model of severe verapamil poisoning: A preliminary descriptive study

Academic Emergency Medicine

Volumn 11, Issue 12, 2004, Pages 1253-1261

  Sztajnkrycer, Matthew D ^a   Bond, G Randall ^a   Johnson, Susan B ^a   Weaver, Amy L ^a  

^a MAYO CLINIC   (United States)

Author keywords

mean arterial pressure; shock; vasopressin; verapamil

Indexed keywords

ARGIPRESSIN; CALCIUM CHANNEL BLOCKING AGENT; SODIUM CHLORIDE; VASOPRESSIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG INTOXICATION; DRUG OVERDOSE; DRUG TOXICITY; HEART INDEX; HEART RATE; HEMODYNAMICS; LABORATORY TEST; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; SERUM; SHOCK; SURVIVAL; TIME;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; OVERDOSE; POISONING; SHOCK; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VERAPAMIL;

EID: 9644302500     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2004.08.035     Document Type: Article

References (33)

1. W.A. Watson, T.L. Litovitz, and G.C. Rodgers 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System Am J Emerg Med 21 2003 353 421
2. D.C. Lee, T. Greene, T. Dougherty, and P. Pearigen Fatal nifedipine ingestions in children J Emerg Med 19 2000 359 361
3. G.R. Bond Calcium channel blocker overdose A.L.L. Harwood-Nuss C.H. Linden G. Sternbach A.B. Wolfson The Clinical Practice of Emergency Medicine ed 3 2001 Lippincott Philadelphia
4. L.R. Moser, M.A. Smythe, and J.E. Tisdale The use of calcium salts in the prevention and management of verapamil-induced hypotension Ann Pharmacother 34 2000 622 629
5. J.A. Kline, C.A. Tomaszewski, J.D. Schroeder, and R.M. Raymond Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine J Pharmacol Exp Ther 267 1993 744 750
6. T.H. Yuan, W.P. Kerns II, C.A. Tomaszewski, M.D. Ford, and J.A. Kline Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning Clin Toxicol 37 1999 463 474
7. L.R. Wolf, M.P. Spadafora, and E.J. Otten Use of amrinone and glucagon in a case of calcium channel blocker overdose Ann Emerg Med 22 1993 1225 1228
8. B. Bailey Glucagon in β-blocker and calcium channel blocker overdoses: a systematic review J Toxiol Clin Toxicol 41 2003 595 602
9. R. Kerns Are we ready to utilize insulin-glucose as routine therapy for calcium channel blocker toxicity? Int J Med Toxicol 1 1998 23
10. J.X. Herbert, C. O'Malley, J.A. Tracey, R. Dwyer, and M. Power Verapamil overdosage unresponsive to dextrose/insulin therapy [abstract] J Toxicol Clin Toxicol 39 2001 293 294
11. D.W. Landry, and J.A. Oliver The pathogenesis of vasodilatory shock N Engl J Med 345 2001 588 595
12. V. Rozenfeld, and J.W.M. Cheng The role of vasopressin in the treatment of vasodilation in shock states Ann Pharmacother 34 2000 250 254
13. S.E. Buijk, and H.A. Bruining Vasopressin deficiency contributes to the vasodilation of septic shock [letter] Circulation 98 1998 187
14. D. Morales, J. Madigan, and S. Cullinane Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock Circulation 100 1999 226 229
15. T.C. Bania, B. Blaufeux, S. Hughes, G.L. Almond, and P. Homel Calcium and digoxin vs calcium alone for severe verapamil toxicity Acad Emerg Med 7 2000 1089 1096
16. H.R. Adams Veterinary Pharmacology and Therapeutics ed 7 1995 Iowa State University Press Ames, IA p 1032
17. E.K. Jackson Vasopressin and other agents affecting the renal conservation of water J.G. Hardman L.E. Limbird Goodman and Gilman's The Pharmacological Basis of Therapeutics ed 10 2001 McGraw-Hill New York 789 808
18. J.K. Robin, J.A. Oliver, and D.W. Landry Vasopressin deficiency in the syndrome of irreversible shock J Trauma 54 2003 S149 S154
19. J.A. Kline, R.M. Raymond, J.D. Schroeder, and J.A. Watts The diabetogenic effects of acute verapamil poisoning Toxicol Appl Pharmacol 145 1997 357 362
20. M. Argenziano, A.F. Choudhri, M.C. Oz, E.A. Rose, C.R. Smith, and D.W. Landry A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement Circulation 96 Suppl II 1997 286 290
21. J.R. Ledsome Atrial receptors, vasopressin and blood volume in the dog Life Sci 36 1985 1315 1330
22. D.M. Philbin, and C.H. Coggins Plasma vasopressin levels during cardiopulmonary bypass with and without profound haemodilution Can Anaesth Soc J 25 1978 282 285
23. C.P. Holstege, M. Mullins, and A.B. Baer Hypotension induced by massive caffeine overdose responsive only to vasopressin infusion [abstract] J Toxicol 39 2001 513
24. J.D. Barry, D.W. Durkovich, and S.R. Williams Vasopressin for hypotension in severe amitriptyline poisoning [abstract] J Toxicol Clin Toxicol 40 2002 622 623
25. J. Gold, S. Cullinane, and J. Chen Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure Am J Cardiol 15 2000 506 508
26. M.W. Dunser, A.J. Mayr, and H. Ulmer The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis Anesth Analg 93 2001 7 13
27. E.B. Rosenzweig, T.J. Starc, and J.M. Chen Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery Circulation 100 Suppl II 1999 182 186
28. W.G. Voelckel, C. Raedler, and V. Wenzel Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs Crit Care Med 31 2003 1160 1165
29. M.W. Dunser, A.J. Mayr, and A. Stallinger Cardiac performance during vasopressin infusion in postcardiotomy shock Intensive Care Med 28 2002 746 751
30. C.L. Holmes, K.R. Walley, D.R. Chittock, T. Lehman, and J.A. Russell The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series Intensive Care Med 27 2001 1416 1421
31. W.L. Jackson Jr., and A.F. Shorr Vasopressin and cardiac performance [letter] Chest 121 2002 1723 1724
32. J.D. Barry, D.W. Durkovitch, and W.H. Richardson Vasopressin treatment of verapamil toxicity in the porcine model [abstract] J Toxicol Clin Toxicol 41 2003 694
33. G. Anfossi, E. Mularoni, and P. Massucco Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation Clin Exp Pharmacol Phys 18 1991 767 773